FDA approves the registration of Enoxaparine for Teva Co., business partner of Chemi, a company belonging to Italfarmaco Group and specialized in the development and characterization of complex molecules, with manufacturing potential including both the active ingredient synthesis and the manufacturing of the new pharmaceutical form of preparations for injections.